June 27

PARIS, June 27, 2011 - Sanofi (EURONEXT: SAN and NYSE: SNY) announced today, at the 71st Scientific American Diabetes Association Sessions 2011, the results of three studies showing that people with diabetes using Sanofi insulins Lantus and/or Apidra with the insulin delivery device SoloSTAR experienced greater treatment satisfaction, better quality of life and lower fear of hypoglycemia vs those using a premixed insulin product.

PARIS, June 27, 2011 - - Human and in vivo Studies Indicate Lantus Metabolites do not Confer Carcinogenic Potential via IGF-1 Receptor Activation Sanofi (EURONEXT: SAN and NYSE: SNY) announced at the 71st American Diabetes Association Scientific Sessions 2011 the results of four studies[1,2,3,4] indicating that the effect of Lantus (insulin glargine) metabolites on the IGF-1 receptor is distinctly different from AspB10, the only insulin analog shown to have a carcinogenic effect.

LONDON, June 27, 2011 - New Model Reflects European Preferences and Attitudes for Accurate Targeting Infectious Media, the intelligent online display specialists, today announced it is working with New York-based Trust Metrics to deliver a custom site-scoring model tailored to the preferences and attitudes of the European market.

MENLO PARK, California, June 27, 2011 - - Protiviti builds on market momentum for its leading internal audit solution by supporting end-to-end internal audit workflow fully integrated with its comprehensive GRC platform Protiviti Inc., a global business consulting and internal audit firm, today announced the addition of a Time & Expense Management module to the Protiviti Governance Portal for Internal Audit.

GRAZ, Austria, June 27, 2011 - - Cross reference: Picture is available via epa european pressphoto agency and can be downloaded free of charge at: www.presseportal.de/pm/101544/ - Christoph Strasser, the Ultrabike World Champion 2007 and 2010, rode the hardest race in the world - and he won the Race Across America with full power! In 2009, he had already tried his luck with the RAAM, but had to cancel due to serious illness.